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IFN-DCs. Migration index in response to concentration gradient of
primary glioma line-derived soluble factors (6 cell lines) ranged
from 32.6 ± 9 to 48.4 ± 15.5. To assess the effect of supernatants
of primary lines on the cytotoxic activity of IFN-DCs four primary
high-grade glioma lines were used. The cytotoxicity of intact LPS-
stimulated donor IFN-DCs against HEp-2 cells was an average of
34.8 ± 7.4%. Supernatant pretreating of IFN-DCs reduced the cyto-
toxic activity of DCs in 8 out of 16 experiments (with an average of
43%). In other 8 cases, supernatants of high-grade glioma lines, in
contrast, possessed a mild stimulating activity and enhanced the
cytotoxicity of DCs on average about of 34%. Thus, tumor cells in
glioma patients produce chemoattractants capable of providing
migration of DCs to tumor. At the same time glioma-derived
soluble factors change the cytotoxic activity both ways. One can
suppose thereupon that impairment of DC cytotoxic activity in
glioma patients occurs not only due to tumor cell impact but
because of unknown mechanisms.
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Glioma is the most common type of primary brain tumor.
Despite aggressive therapy, glioma virtually always recurs. Sol-
uble factors produced by glioma cells play an important role in
progression of tumor growth. Glioma-derived soluble factors
can stimulate tumor cell proliferation in autocrine and paracrine
manners, affect the tumor microenvironment and promote
angiogenesis and metastasis. Besides, glioma-derived cytokines
are able to disturb antitumor immune response by inhibiting
the functions of effector lymphocytes and inducing immunosup-
pressive cells. The aim of the present study was to determine the
profile of cytokines produced by primary low-grade and high-
grade glioma cell cultures. The study was held in 21 patients with
brain tumors after receiving a written informed consent. There
were 6 patients with histologically verified low-grade glioma
(Grade II) and 15 patients – with high-grade glioma (Grade III–
IV). Tumor tissues from patients were obtained during surgical
resection. Cell suspensions were prepared by mechanical and
enzymatic disaggregation followed by culturing in DMEM/F12
medium containing 10% FCS. The levels of 27 cytokines were
measured using multiplex analysis (Bio-Rad, USA) in 7-days
supernatants collected upon reaching the cellular subconfluence.
Low-grade glioma cells produced low level (Me <25 pg/ml) of pro-
inflammatory cytokines IL-1b, TNFa and anti-inflammatory
cytokines IL1-ra, IL-10, IL-13. The level of these cytokines in
supernatants of high-grade glioma cultures were in the middle
range (25–500 pg/ml), excepting IL-1b (Me 5.9 pg/ml). Concerning
cytokines with immunoregulatory activity in supernatants of
low-grade glioma cultures, only IL-12 level was in the middle
range (Me 77 pg/ml), whereas the level of other immunoregula-
tory cytokines (IL-2, IFNc, IL-4, IL-5, IL-15, IL-17) was low (Me
<25 pg/ml). High-grade glioma cells actively produced not only
IL-12 (Me 336 pg/ml), but also IFNc and IL-15 (Me 355 pg/ml and
Me 57 pg/ml, respectively). The level of growth factors and cytoki-
nes, which act as regulators of hemo- and immunopoesis, was
low in supernatants of low-grade glioma cultures. Median con-
centration of G-CSF, GM-CSF, IL-7, FGFb and PDGF was less than
25 pg/ml, but IL-9 concentration was in the middle range (Me
74 pg/ml) . High-grade glioma cultures produced, besides IL-9,
also G-GSF (Me 263 pg/ml), FGFb (Me 60 pg/ml) and PDGF (Me
63 pg/ml). The level of FGFb and G-GSF correlated with the glioma
grade (R = 0.87, p = 0.002, and R = 0.66, p = 0.002, respectively). The
IL-7 and GM-CSF level in high-grade culture supernatant was low
(Me <25 pg/ml). IL-6 and VEGF play important role in the mainte-
nance of tumor cell proliferation and the stimulation of tumor
angiogenesis. Both low-grade and high-grade glioma cultures pro-
duced high level (>500 pg/ml) of IL-6 (Me 1933 pg/ml and 3531 pg/ml,
respectively) and VEGF (Me 1004 pg/ml and 14887 pg/ml, respec-
tively). VEGF level correlated with glioma grade (R = 0.86,
p = 0.002). Concerning CC-chemokines the level of Eotaxin was
low in low-grade glioma cultures (Me 11 pg/ml). The mild-level
production was found for MIP-1a (Me 71 pg/ml) and RANTES
(231 pg/ml), high-level – for MCP-1 (Me 9468 pg/ml) and MIP-1b
(Me 990 pg/ml). High-grade glioma cells produced not only MIP-
1a (Me 208 pg/ml) and RANTES (Me 311 pg/ml) in the middle range
but also Eotaxin (Me 107 pg/ml). Eotaxin level correlated with the
glioma grade (R = 0.87, p = 0.002). High-grade glioma cells pro-
duced highlevel of MCP-1 (Me 9868 pg/ml) and MIP-1b (Me
1923 pg/ml). Both low-grade and high-grade glioma cells
produced high level of CXC-chemokines IL-8 and IP-10 (Me
>1000 pg/ml). The level of IL-8, which acts as chemoattractant
for immune cells as well as for endothelial cells involved in angio-
genesis, correlated with glioma grades (R = 0.72, p = 0.002). Thus,
the grade of gliomas associated with broadening the spectrum
of cytokines and enhanced level of cytokines production by tumor
cells.
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Exosomes are small vesicles formed in vesicular bodies in the
endosomal network many different types of cells. Exosomes are
abundantly released by tumor cells. Current knowledge of exo-
somes suggests that they can play an important role in the devel-
opment and progression of cancer through modulation of
intercellular communication within the tumour microenviron-
ment by the transfer of protein, lipid, and RNA cargo.
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Hepatocellular carcinoma is the most common primary malig-
nancy of the liver. HepG2 represents a pure cell line of human
liver carcinoma. The purpose of the current study was character-
ization of exosomes derived from HepG2 cells line.
Exosomes were isolated from HepG2 cell culture supernatant
by a series of subsequent centrifugation steps. Morphology of
exosomes was determined by electron microscopy. To character-
ize HepG2 cell derived exosomes we also examined the presence
of the ER-residing protein Calnexin by Western blot. Data showed
that Calnexin was absent in exosomes. Taken together, these
results indicate that vesicles obtained from cell-free supernatants
of HepG2 cells exhibit properties of exosomes.
Proteome analysis was performed for proteins commonly
expressed in HepG2 cells such as cytochromes P450 that serve
important roles in the cellular detoxification process and drug
metabolism. We identified members of protein families cyto-
chromes P450 CYP1A1 b CYP1A2 in both HepG2 cells and
exosomes.
Thus, hepatocyte-derived exosome population should be use-
ful in our further understanding of the hepatic function and in
the identification of components that may serve as biomarkers
for hepatic alterations. These tumor-derived extracellular vesicles
represent a mediator of the tumor microenvironment, and their
presence in the peripheral circulation may serve as a surrogate
for tumor biopsies, enabling real-time diagnosis and disease
monitoring.
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Background: TP53 dysfunction is implicated in lymphomagen-
esis and disease progression. Information about the frequency
and spectrum of TP53 mutations in the Russian pathients with
diffuse large B-cell lymphoma (DLBCL) in the current version of
the IARC TP53 Mutation Database R17 is not represented. The goal
of this work was to study the frequency, spectrum and functional
significance of TP53 mutations in Russian patients with DLBCL.
Material and methods: At the present time the pilot group of 14
patients were included in the study. Diagnosis was assessed
according to the criteria of the WHO classification system.
Genomic DNA was isolated from formalin-fixed, paraffin embed-
ded tissue blocks. Direct sequence analysis of gene TP53 was
performed according to the IARC protocol, 2010 update.
Results: In two patients were identified single nucleotide sub-
stitutions that are not described in the current version of the
PubMed database. All of mutations occurred in the DNA-binding
domain of p53. The nonsense mutation Arg196Ter was detected
in one patient. Previously it was shown that formation of this
premature stop codon might activate the nonsense-mediated
RNA decay pathway. The second patient had two missense muta-
tions – Leu130Phe and Arg156Cys. The first of them leads to p53
inactivation according to the analysis of the functional impor-
tance of amino acid substitutions using service PolyPhen-2.
Conclusion: We detected TP53 mutation in 14% cases. The
mutational rate in our study is in good agreement with other
studies where the frequency of the TP53 mutations in patients
with DLBCL ranged mostly from 13% to 23%.
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Nowadays the term ‘‘epigenetics” is described as regulation of
gene expression persisting from one cell division to the next,
despite a lack of changes in the underlying DNA sequence. The
‘‘epigenome” refers to different epigenetic states of a cell recog-
nized as heritable environment influence on genome. The main
epigenetic phenomena in mammals are DNA methylation and
histone modifications, which are tightly interdependent. Many
authors classify microRNA regulation as a third epigenetic phe-
nomenon. Moreover, recently the discussion has been open that
many different factors modifying DNA conformation represent
a new class of epigenetic agents. In response to various environ-
mental stimuli, cells produce different epigenetic changes that
determine either an active or a repressed chromatin state.
Epigenetic perturbations have been shown to associate with
exposure to a range of drugs and toxicants, including non-
genotoxic carcinogens. Consequently, on one hand, potential
impact of epigenomics on drug development is under considera-
tion as even well-known pharmacological drugs were shown to
cause epigenetic changes that may be beneficial or hazardous.
In particular, epigenetic effects were described for synthetic
estrogens and contraceptives, beta-blockers and fluoroquinolone
antibiotics, neuroleptics and anesthetics, chemotherapeutics and
statins. Drug influence on gene silencing might have some
therapeutic advantage in addition to the unfavourable effects.
In particular, valproate, hydralazine and procainamide might be
utilized to induce gene expression in cancers, where activation
of a methylated gene might be of benefit. Screening of xenobiotics
for epigenetic activity might identify new potential drugs for
some specific diseases.
On the other hand, epigenetic aspects of drug safety are inves-
tigated intensively. Many recent reviews in this field of research
were devoted to the test elaboration for revealing different
short-term and longer-lasting epigenetic changes modifying gene
expression. Most of the short-term epigenetic screening tests are
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